The objective of the Preclinical Development Program (PDEV) is to accelerate completion of preclinical development, FDA IND clearance, and clinical trial startup for stem cell-based and genetic ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

The mission of the California Institute for Regenerative Medicine (CIRM) is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a ...

South San Francisco, CA, April 24, 2025 — The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has approved awarding ...

Candidato terapéutico o dispositivo Plurocart consiste en condrocitos derivados de células madre pluripotentes, sembrados en un armazón; está destinado a tratar el cartílago dañado en la articulación ...

Sphingosine phosphate lyase insufficiency syndrome (SPLIS) is a rare genetic condition caused by mutations in the SGPL1 gene. This gene encodes an essential enzyme needed to metabolize a group of ...

AB-205-301 is a Phase 3 clinical study, intended to determine if the experimental therapy AB-205 is safe and effective for US FDA approval in its use with blood stem cell transplants used to cure ...

Genome sequencing in the clinic often allows patients to receive a molecular diagnosis. However, variants are most often evaluated for pathogenicity, neglecting potential treatability and thus often ...

研究目标：本项目将探究高可信度神经精神疾病风险蛋白的相互作用、分布和功能，并识别患者基因变异的趋同病理生物学 ...

Gene therapy achieves therapeutic benefits by delivering genetic materials, packaged within a delivery vehicle, to target cells with defective genes. This approach has shown promise in treating ...

Objetivo de la investigación Un nuevo tipo de APC sirve a los pacientes mayores como 1) mejor MSC en inmunomodulación (reducción de la inflamación) para el ...

Objetivo de la investigación Células CAR-iNKT (AlloMCAR-iNKT) dirigidas a mesotelina alogénica diseñada por HSC Impacto en el tratamiento del cáncer de ovario Principales actividades propuestas Hito 1 ...